Carlisle Companies Incorporated
US ˙ NYSE ˙ US1423391002

SecurityCSL / Carlisle Companies Incorporated
InsiderRoche Robert M.
This page shows the track record and history of Roche Robert M. insider trades in Carlisle Companies Incorporated. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Roche Robert M. in CSL / Carlisle Companies Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CSL / Carlisle Companies Incorporated Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Roche Robert M. in CSL / Carlisle Companies Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2021-08-25 8,296 211.0400 8,296 211.0400 1,750,788 20 195.53 -128,670 -7.35
2021-08-25 2,184 210.5900 2,184 210.5900 459,929
2021-05-26 6,550 192.0000 6,550 192.0000 1,257,600
2021-05-26 6,130 192.2600 6,130 192.2600 1,178,554
2020-12-04 5,600 150.0300 5,600 150.0300 840,168
2020-11-25 400 150.0000 400 150.0000 60,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CSL / Carlisle Companies Incorporated Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2022-03-01 2022-03-01 4 Roche Robert M. CSL Common Stock F - Taxes D 231.6500 -2,503 -580 23,263
2022-01-05 2022-01-03 4 Roche Robert M. CSL Common Stock F - Taxes D 248.1200 -3,207 -796 25,766
2022-01-05 2022-01-03 4 Roche Robert M. CSL Common Stock A - Award D 5,670 28,973
2021-08-25 2021-08-25 4 Roche Robert M. CSL Employee Stock Option (Right to Buy) M - Exercise D 108.72 -8,296 4,149
2021-08-25 2021-08-25 4 Roche Robert M. CSL Common Stock S - Sale D 210.5900 -2,184 -460 23,303
2021-08-25 2021-08-25 4 Roche Robert M. CSL Common Stock S - Sale D 211.0400 -8,296 -1,751 25,487
2021-08-25 2021-08-25 4 Roche Robert M. CSL Common Stock M - Exercise D 108.7200 8,296 902 33,783
2021-05-26 2021-05-26 4 Roche Robert M. CSL Employee Stock Option (Right to Buy) M - Exercise D 105.03 -6,130 0
2021-05-26 2021-05-26 4 Roche Robert M. CSL Common Stock S - Sale D 192.2600 -6,130 -1,179 25,487
2021-05-26 2021-05-26 4 Roche Robert M. CSL Common Stock M - Exercise D 105.0300 6,130 644 31,617
2021-05-26 2021-05-26 4 Roche Robert M. CSL Common Stock S - Sale D 192.0000 -6,550 -1,258 25,487
2021-02-03 2021-02-02 4 Roche Robert M. CSL Employee Stock Option (Right to Buy) A - Award D 150.00 13,755 13,755
2021-02-03 2021-02-02 4 Roche Robert M. CSL Common Stock A - Award D 5,920 32,037
2021-01-05 2021-01-01 4 Roche Robert M. CSL Common Stock F - Taxes D 156.1800 -1,564 -244 26,117
2021-01-05 2021-01-01 4 Roche Robert M. CSL Common Stock A - Award D 5,155 27,681
2020-12-07 2020-12-04 4 Roche Robert M. CSL Employee Stock Option (Right to Buy) M - Exercise D 105.03 -5,600 6,130
2020-12-07 2020-12-04 4 Roche Robert M. CSL Common Stock S - Sale D 150.0300 -5,600 -840 22,526
2020-12-07 2020-12-04 4 Roche Robert M. CSL Common Stock M - Exercise D 105.0300 5,600 588 28,126
2020-11-30 2020-11-25 4 Roche Robert M. CSL Employee Stock Option (Right to Buy) M - Exercise D 105.03 -400 11,730
2020-11-30 2020-11-25 4 Roche Robert M. CSL Common Stock S - Sale D 150.0000 -400 -60 22,526
2020-11-30 2020-11-25 4 Roche Robert M. CSL Common Stock M - Exercise D 105.0300 400 42 22,926
2020-02-05 2020-02-04 4 Roche Robert M. CSL Employee Stock Option (Right to Buy) A - Award D 161.41 14,460 14,460
2020-02-05 2020-02-04 4 Roche Robert M. CSL Common Stock A - Award D 2,670 22,526
2020-01-02 2020-01-01 4 Roche Robert M. CSL Common Stock F - Taxes D 161.8400 -1,696 -274 19,856
2020-01-02 2020-01-01 4 Roche Robert M. CSL Common Stock A - Award D 4,938 21,552
2019-02-19 2019-02-15 4 Roche Robert M. CSL Common Stock F - Taxes D 121.4200 -579 -70 16,614
2019-02-06 2019-02-05 4 Roche Robert M. CSL Employee Stock Option (Right to Buy) A - Award D 110.79 14,935 14,935
2019-02-06 2019-02-05 4 Roche Robert M. CSL Common Stock A - Award D 2,835 17,193
2018-02-16 2018-02-15 4 Roche Robert M. CSL Common Stock F - Taxes D 107.2900 -579 -62 14,358
2018-02-07 2018-02-06 4 Roche Robert M. CSL Employee Stock Option (Right to Buy) A - Award D 108.72 12,445 12,445
2018-02-07 2018-02-06 4 Roche Robert M. CSL Common Stock A - Award D 2,700 14,937
2017-02-17 2017-02-15 4 Roche Robert M. CSL Common Stock Options A - Award D 105.03 12,130 12,130
2017-02-17 2017-02-15 4 Roche Robert M. CSL Common Stock A - Award D 2,715 12,237
2017-02-17 2017-02-15 4 Roche Robert M. CSL Common Stock A - Award D 9,522 9,522
2017-02-15 3 Roche Robert M. CSL Common Stock D 0
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)